The short-term increase in alcohol consumption during the COVID-19 pandemic is expected to substantially increase the morbidity and mortality associated with long-term alcohol-related liver disease.
The purpose of the biocompatible ALD barrier layers is to protect the microelectronic components of the devices without interfering with the device functionality.